Tenax Therapeutics (TENX) Invested Capital: 2011-2017
Historic Invested Capital for Tenax Therapeutics (TENX) over the last 4 years, with Sep 2017 value amounting to $10.2 million.
- Tenax Therapeutics' Invested Capital fell 78.23% to $10.2 million in Q3 2017 from the same period last year, while for Sep 2017 it was $10.2 million, marking a year-over-year decrease of 78.23%. This contributed to the annual value of $17.1 million for FY2016, which is N/A change from last year.
- According to the latest figures from Q3 2017, Tenax Therapeutics' Invested Capital is $10.2 million, which was down 9.78% from $11.3 million recorded in Q2 2017.
- Tenax Therapeutics' 5-year Invested Capital high stood at $82.9 million for Q2 2014, and its period low was -$1.8 million during Q2 2013.
- Its 3-year average for Invested Capital is $35.1 million, with a median of $31.9 million in 2016.
- Per our database at Business Quant, Tenax Therapeutics' Invested Capital tumbled by 413.81% in 2013 and then surged by 4,759.94% in 2014.
- Tenax Therapeutics' Invested Capital (Quarterly) stood at -$1.8 million in 2013, then spiked by 4,759.94% to $82.9 million in 2014, then decreased by 15.00% to $60.4 million in 2015, then slumped by 71.63% to $17.1 million in 2016, then tumbled by 78.23% to $10.2 million in 2017.
- Its Invested Capital was $10.2 million in Q3 2017, compared to $11.3 million in Q2 2017 and $14.1 million in Q1 2017.